| P2093 | author name string | Bluestein HG | |
| | Hasler F | |
| P2860 | cites work | Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis | Q33981648 |
| | Antibodies to cellular antigens in Sjögren's syndrome | Q34478675 |
| | Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes | Q36335723 |
| | Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis | Q36340125 |
| | In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects | Q36342050 |
| | Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation | Q36347266 |
| | Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis | Q36996340 |
| | Elevated Levels of Antibodies to Epstein-Barr Virus Antigens in Sera and Synovial Fluids of Patients with Rheumatoid Arthritis | Q36997772 |
| | Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection | Q37022893 |
| | Long-term T-cell-mediated immunity to epstein-barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes | Q40189656 |
| | Long-term T-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures | Q40238398 |
| | Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures | Q40238404 |
| | Inhibition of the in vitro outgrowth of Epstein-Barr virus-infected lymphocytes by TG lymphocytes | Q40260453 |
| | Anti-RANA antibody: a marker for seronegative and seropositive rheumatoid arthritis | Q43765322 |
| | T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals | Q43826614 |
| | Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Demonstration by precipitation and immunofluorescence | Q44042718 |
| | Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells | Q44495439 |
| | Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect | Q44840393 |
| | Oropharyngeal Epstein-Barr virus excretion in rheumatoid arthritis | Q45800448 |
| | Titers of antibodies to RANA in rheumatoid arthritis and normal sera. Relationship to Epstein-Barr virus infection | Q45800864 |
| | Altered regulation of epstein-barr virus induced lymphoblast proliferation in rheumatoid arthritis lymphoid cells | Q45803516 |
| | HLA-restricted T-cell recognition of Epstein–Barr virus-infected B cells | Q45803868 |
| | The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon | Q45805720 |
| | T lymphocyte-mediated cytotoxicity against autologous EBV-genome-bearing B cells | Q72631875 |
| | Defective EBV-specific suppressor T-cell function in rheumatoid arthritis | Q72909806 |
| P433 | issue | 1 | |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 70-77 | |
| P577 | publication date | 1984-01-01 | |
| P1433 | published in | Survey of immunologic research | Q27713187 |
| P1476 | title | Epstein-Barr virus and rheumatoid arthritis | |
| P478 | volume | 3 | |